Alzheimer’s Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostics Technique (Biomarkers, Imaging Techniques), By Type (Triage, Diagnosis), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Alzheimer’s Disease Diagnostics Market Growth & Trends
The global Alzheimer’s disease diagnostics market size is expected to reach USD 15.92 billion by 2030, registering a CAGR of 11.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising prevalence of Alzheimer’s disease (AD), growing use of biomarkers in disease diagnostics, growing adoption of personalized products, and increasing technological advancements in medical imaging are some of the factors which is expected to drive the demand for Alzheimer’s disease diagnostics. Increasing government investments and R&D studies is further propelling growth.
The global aging population with chronic conditions such as Alzheimer’s disease, which is the most common form of dementia, is another major factor driving the market for Alzheimer’s disease diagnostics. According to the WHO, Alzheimer’s disease causes 60–70% of all instances of dementia, making it the most common kind. According to the Alzheimer’s Association reports, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer’s disease in 2023. This number is projected to nearly triple to 13.8 million people by 2060, and the studies project that the healthcare cost for AD patients in 2022 was around USD 321 billion in the U.S, itself.
The market trends are shifting towards the development of more accurate and non-invasive diagnostic tools. Recent advances in technology have led to the development of biomarkers, such as amyloid-beta and tau proteins, which can be detected in cerebrospinal fluid or blood samples. These biomarkers have shown promise in detecting Alzheimer’s disease in its early stages, allowing for earlier intervention and treatment. Additionally, advances in neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), have improved the accuracy of Alzheimer’s disease diagnosis.
Recent examples of innovative diagnostic technologies for Alzheimer’s disease include the development of blood-based biomarkers, such as the p-tau217 test, which has shown high accuracy in detecting the disease. Another example is the use of digital biomarkers, such as cognitive assessments and wearable devices, to track cognitive decline and identify early signs of Alzheimer’s disease. Companies such as Biogen and Eisai are also investing in digital health technologies to support clinical trials and improve patient outcomes. Moreover, researchers are exploring the potential of machine learning and natural language processing to analyze speech patterns and identify early signs of cognitive decline. These advances in diagnostic technology are expected to revolutionize the field of Alzheimer’s disease diagnosis, enabling earlier intervention and more effective treatment strategies.
Presence of government funding programs aimed at reducing the burden of orthopedic diseases, by funding various clinical trials aimed at, is expected to have a positive impact on the market, In addition, governments are allocating substantial funds for research and development (R&D) in the field of Alzheimer’s diagnostics. This funding supports the development of new diagnostic technologies, such as advanced imaging techniques, biomarker assays, and cognitive assessment tools. Increased R&D investment accelerates the pace of innovation and helps bring new diagnostic solutions to the market
Some of the key players in the market are Quest Diagnostics, Labcorp, C2N Diagnostics, Fujirebio, Bristol Myers Squibb, Hoffmann-La Roche, and Quanterix. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele. For instance, in April 2024, Quest Diagnostics announced its portfolio expansion by adding a new blood biomarker test for phosphorylated tau 217 (p-tau217). Companies further have been innovating in various blood-based biomarkers, cerebrospinal fluid tests, and genetic tests to provide a comprehensive offering in brain health.
Alzheimer’s Disease Diagnostics Market Report Highlights
Alzheimer’s Disease Diagnostics Market Growth & Trends
The global Alzheimer’s disease diagnostics market size is expected to reach USD 15.92 billion by 2030, registering a CAGR of 11.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising prevalence of Alzheimer’s disease (AD), growing use of biomarkers in disease diagnostics, growing adoption of personalized products, and increasing technological advancements in medical imaging are some of the factors which is expected to drive the demand for Alzheimer’s disease diagnostics. Increasing government investments and R&D studies is further propelling growth.
The global aging population with chronic conditions such as Alzheimer’s disease, which is the most common form of dementia, is another major factor driving the market for Alzheimer’s disease diagnostics. According to the WHO, Alzheimer’s disease causes 60–70% of all instances of dementia, making it the most common kind. According to the Alzheimer’s Association reports, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer’s disease in 2023. This number is projected to nearly triple to 13.8 million people by 2060, and the studies project that the healthcare cost for AD patients in 2022 was around USD 321 billion in the U.S, itself.
The market trends are shifting towards the development of more accurate and non-invasive diagnostic tools. Recent advances in technology have led to the development of biomarkers, such as amyloid-beta and tau proteins, which can be detected in cerebrospinal fluid or blood samples. These biomarkers have shown promise in detecting Alzheimer’s disease in its early stages, allowing for earlier intervention and treatment. Additionally, advances in neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), have improved the accuracy of Alzheimer’s disease diagnosis.
Recent examples of innovative diagnostic technologies for Alzheimer’s disease include the development of blood-based biomarkers, such as the p-tau217 test, which has shown high accuracy in detecting the disease. Another example is the use of digital biomarkers, such as cognitive assessments and wearable devices, to track cognitive decline and identify early signs of Alzheimer’s disease. Companies such as Biogen and Eisai are also investing in digital health technologies to support clinical trials and improve patient outcomes. Moreover, researchers are exploring the potential of machine learning and natural language processing to analyze speech patterns and identify early signs of cognitive decline. These advances in diagnostic technology are expected to revolutionize the field of Alzheimer’s disease diagnosis, enabling earlier intervention and more effective treatment strategies.
Presence of government funding programs aimed at reducing the burden of orthopedic diseases, by funding various clinical trials aimed at, is expected to have a positive impact on the market, In addition, governments are allocating substantial funds for research and development (R&D) in the field of Alzheimer’s diagnostics. This funding supports the development of new diagnostic technologies, such as advanced imaging techniques, biomarker assays, and cognitive assessment tools. Increased R&D investment accelerates the pace of innovation and helps bring new diagnostic solutions to the market
Some of the key players in the market are Quest Diagnostics, Labcorp, C2N Diagnostics, Fujirebio, Bristol Myers Squibb, Hoffmann-La Roche, and Quanterix. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele. For instance, in April 2024, Quest Diagnostics announced its portfolio expansion by adding a new blood biomarker test for phosphorylated tau 217 (p-tau217). Companies further have been innovating in various blood-based biomarkers, cerebrospinal fluid tests, and genetic tests to provide a comprehensive offering in brain health.
Alzheimer’s Disease Diagnostics Market Report Highlights
- Based on diagnostics technique, imaging techniques accounted for the largest revenue share in 2023. Such initiatives are expected to drive market growth. This high share is attributable to the urgent need for early and accurate detection of the disease. Advancements in imaging technologies such as Computed Tomography (CT), Positron Emission Tomography (PET), functional MRI (fMRI) have emerged as crucial tools for diagnosing and monitoring the disease.
- Based on type, diagnosis dominated the market and accounted for the largest share in 2023. The global market is expanding as the aging population rises, with more individuals at risk of developing Alzheimer’s disease. This has heightened the demand for early and accurate diagnostic tools, driving the market forward.
- Based on end use, academic and research institutes segment dominated the market with the largest market share in 2023. This is attributable to the increase in the research studies and clinical trials for neurological disorders over the last decade. Academic and research institutes are at the forefront of advanced research, clinical trials, and the development of innovative diagnostic techniques.
- North America dominated the global market due to the presence of a large number of major market players at the forefront of research into Alzheimer’s disease biomarkers, including cerebrospinal fluid analysis and blood-based biomarkers. These advancements are driving the development of more accurate and minimally invasive diagnostic tests.
- Asia Pacific region is expected to witness the fastest growth over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Diagnostics Technique
1.2.2. Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Diagnostics Technique outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of Alzheimer’s disease
3.2.1.2. Increasing use of biomarkers in diagnosis
3.2.1.3. Growing adoption of personalized products
3.2.1.4. Growing R&D studies and government investments
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. Alzheimer’s Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.2. PESTEL Analysis
CHAPTER 4. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: DIAGNOSTICS TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Alzheimer’s Disease Diagnostics Market: Diagnostics Technique Movement Analysis
4.3. Alzheimer’s Disease Diagnostics Market Size & Trend Analysis, by diagnostic technique, 2018 to 2030 (USD Million)
4.4. Biomarker
4.4.1. Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. CSF Biomarkers
4.4.2.1. CSF Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Blood Based Biomarker
4.4.3.1. Blood Based Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Imaging Techniques
4.5.1. Imaging Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Genetic Testing
4.6.1. Genetic Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Cognitive Assessment Tests
4.7.1. Cognitive Assessment Tests Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: TYPE ESTIMATES & TREND ANALYSIS
5.1. Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Alzheimer’s Disease Diagnostics Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Triage
5.5.1. Triage Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Diagnosis
5.6.1. Diagnosis Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Screening
5.7.1. Screening Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Alzheimer’s Disease Diagnostics Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Laboratories
6.6.1. Diagnostic Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Academic and Research Institutes
6.7.1. Academic and Research Institutes Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. North America: SWOT Analysis
7.5.2. U.S.
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/Reimbursement
7.5.2.3. Competitive scenario
7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/Reimbursement
7.5.3.3. Competitive scenario
7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/Reimbursement
7.5.4.3. Competitive scenario
7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. Europe: SWOT Analysis
7.6.2. UK
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/Reimbursement
7.6.2.3. Competitive scenario
7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Germany
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/Reimbursement
7.6.3.3. Competitive scenario
7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. France
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/Reimbursement
7.6.4.3. Competitive scenario
7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Italy
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/Reimbursement
7.6.5.3. Competitive scenario
7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Spain
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/Reimbursement
7.6.6.3. Competitive scenario
7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Norway
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/Reimbursement
7.6.7.3. Competitive scenario
7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/Reimbursement
7.6.8.3. Competitive scenario
7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.9. Denmark
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework/Reimbursement
7.6.9.3. Competitive scenario
7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Asia Pacific: SWOT Analysis
7.7.2. Japan
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/Reimbursement
7.7.2.3. Competitive scenario
7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. China
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/Reimbursement
7.7.3.3. Competitive scenario
7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. India
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/Reimbursement
7.7.4.3. Competitive scenario
7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. Australia
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/Reimbursement
7.7.5.3. Competitive scenario
7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. South Korea
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/Reimbursement
7.7.6.3. Competitive scenario
7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.7. Thailand
7.7.7.1. Key country dynamics
7.7.7.2. Regulatory framework/Reimbursement
7.7.7.3. Competitive scenario
7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Latin America: SWOT Analysis
7.8.2. Brazil
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/Reimbursement
7.8.2.3. Competitive scenario
7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/Reimbursement
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. MEA: SWOT Analysis
7.9.2. South Africa
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/Reimbursement
7.9.2.3. Competitive scenario
7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. Saudi Arabia
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/Reimbursement
7.9.3.3. Competitive scenario
7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. UAE
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/Reimbursement
7.9.4.3. Competitive scenario
7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.5. Kuwait
7.9.5.1. Key country dynamics
7.9.5.2. Regulatory framework
7.9.5.3. Competitive scenario
7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Quest Diagnostics Incorporated
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Services benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Laboratory Corporation of America Holdings
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Services benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche Ltd.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Services benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Siemens Healthineers AG
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Services benchmarking
8.3.7.4. Strategic initiatives
8.3.8. C2N diagnostics
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Services benchmarking
8.3.8.4. Strategic initiatives
8.3.9. FujireBio
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Services benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Bristol Myers Squibb Company
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Services benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Quanterix
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Services benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Sysmex
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Services benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Lantheus
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Services benchmarking
8.3.13.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Diagnostics Technique
1.2.2. Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Diagnostics Technique outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of Alzheimer’s disease
3.2.1.2. Increasing use of biomarkers in diagnosis
3.2.1.3. Growing adoption of personalized products
3.2.1.4. Growing R&D studies and government investments
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. Alzheimer’s Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.2. PESTEL Analysis
CHAPTER 4. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: DIAGNOSTICS TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Alzheimer’s Disease Diagnostics Market: Diagnostics Technique Movement Analysis
4.3. Alzheimer’s Disease Diagnostics Market Size & Trend Analysis, by diagnostic technique, 2018 to 2030 (USD Million)
4.4. Biomarker
4.4.1. Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. CSF Biomarkers
4.4.2.1. CSF Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Blood Based Biomarker
4.4.3.1. Blood Based Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Imaging Techniques
4.5.1. Imaging Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Genetic Testing
4.6.1. Genetic Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Cognitive Assessment Tests
4.7.1. Cognitive Assessment Tests Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: TYPE ESTIMATES & TREND ANALYSIS
5.1. Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Alzheimer’s Disease Diagnostics Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Triage
5.5.1. Triage Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Diagnosis
5.6.1. Diagnosis Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Screening
5.7.1. Screening Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Alzheimer’s Disease Diagnostics Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Laboratories
6.6.1. Diagnostic Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Academic and Research Institutes
6.7.1. Academic and Research Institutes Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. ALZHEIMER’S DISEASE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. North America: SWOT Analysis
7.5.2. U.S.
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/Reimbursement
7.5.2.3. Competitive scenario
7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/Reimbursement
7.5.3.3. Competitive scenario
7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/Reimbursement
7.5.4.3. Competitive scenario
7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. Europe: SWOT Analysis
7.6.2. UK
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/Reimbursement
7.6.2.3. Competitive scenario
7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Germany
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/Reimbursement
7.6.3.3. Competitive scenario
7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. France
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/Reimbursement
7.6.4.3. Competitive scenario
7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Italy
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/Reimbursement
7.6.5.3. Competitive scenario
7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Spain
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/Reimbursement
7.6.6.3. Competitive scenario
7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Norway
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/Reimbursement
7.6.7.3. Competitive scenario
7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/Reimbursement
7.6.8.3. Competitive scenario
7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.9. Denmark
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework/Reimbursement
7.6.9.3. Competitive scenario
7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Asia Pacific: SWOT Analysis
7.7.2. Japan
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/Reimbursement
7.7.2.3. Competitive scenario
7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. China
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/Reimbursement
7.7.3.3. Competitive scenario
7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. India
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/Reimbursement
7.7.4.3. Competitive scenario
7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. Australia
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/Reimbursement
7.7.5.3. Competitive scenario
7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. South Korea
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/Reimbursement
7.7.6.3. Competitive scenario
7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.7. Thailand
7.7.7.1. Key country dynamics
7.7.7.2. Regulatory framework/Reimbursement
7.7.7.3. Competitive scenario
7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Latin America: SWOT Analysis
7.8.2. Brazil
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/Reimbursement
7.8.2.3. Competitive scenario
7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/Reimbursement
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. MEA: SWOT Analysis
7.9.2. South Africa
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/Reimbursement
7.9.2.3. Competitive scenario
7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. Saudi Arabia
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/Reimbursement
7.9.3.3. Competitive scenario
7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. UAE
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/Reimbursement
7.9.4.3. Competitive scenario
7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.5. Kuwait
7.9.5.1. Key country dynamics
7.9.5.2. Regulatory framework
7.9.5.3. Competitive scenario
7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Quest Diagnostics Incorporated
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Services benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Laboratory Corporation of America Holdings
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Services benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche Ltd.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Services benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Siemens Healthineers AG
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Services benchmarking
8.3.7.4. Strategic initiatives
8.3.8. C2N diagnostics
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Services benchmarking
8.3.8.4. Strategic initiatives
8.3.9. FujireBio
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Services benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Bristol Myers Squibb Company
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Services benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Quanterix
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Services benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Sysmex
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Services benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Lantheus
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Services benchmarking
8.3.13.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 North America Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 4 North America Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 5 North America Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 7 U.S. Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 10 Canada Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 13 Mexico Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 14 Mexico Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 16 Europe Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 17 Europe Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 18 Europe Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 Germany Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 20 Germany Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Germany Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 22 UK Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 23 UK Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 24 UK Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 25 France Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 26 France Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 France Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 29 Italy Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 30 Italy Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 31 Spain Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 32 Spain Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 33 Spain Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 34 Denmark Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 35 Denmark Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 Denmark Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Sweden Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 38 Sweden Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 39 Sweden Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 40 Norway Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 41 Norway Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 42 Norway Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 47 China Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 48 China Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 China Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 50 Japan Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 51 Japan Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 52 Japan Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 53 India Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 54 India Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 55 India Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 57 South Korea Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 South Korea Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 59 Australia Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 60 Australia Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 61 Australia Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 62 Thailand Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 63 Thailand Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 64 Thailand Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 66 Latin America Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 67 Latin America Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 68 Brazil Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 69 Brazil Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 70 Brazil Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 71 Argentina Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 72 Argentina Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 74 MEA Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 75 MEA Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 76 MEA Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 77 MEA Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 78 South Africa Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 79 South Africa Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 84 UAE Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 85 UAE Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 86 UAE Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 87 Kuwait Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 88 Kuwait Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 North America Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 4 North America Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 5 North America Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 7 U.S. Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 10 Canada Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 13 Mexico Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 14 Mexico Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 16 Europe Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 17 Europe Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 18 Europe Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 Germany Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 20 Germany Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Germany Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 22 UK Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 23 UK Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 24 UK Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 25 France Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 26 France Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 France Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 29 Italy Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 30 Italy Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 31 Spain Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 32 Spain Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 33 Spain Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 34 Denmark Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 35 Denmark Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 Denmark Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Sweden Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 38 Sweden Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 39 Sweden Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 40 Norway Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 41 Norway Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 42 Norway Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 47 China Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 48 China Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 China Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 50 Japan Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 51 Japan Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 52 Japan Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 53 India Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 54 India Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 55 India Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 57 South Korea Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 South Korea Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 59 Australia Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 60 Australia Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 61 Australia Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 62 Thailand Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 63 Thailand Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 64 Thailand Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 66 Latin America Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 67 Latin America Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 68 Brazil Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 69 Brazil Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 70 Brazil Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 71 Argentina Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 72 Argentina Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 74 MEA Alzheimer’s disease diagnostics market, by region, 2018 - 2030 (USD Million)
Table 75 MEA Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 76 MEA Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 77 MEA Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 78 South Africa Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 79 South Africa Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 84 UAE Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 85 UAE Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 86 UAE Alzheimer’s disease diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 87 Kuwait Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 88 Kuwait Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alzheimer’s disease diagnostics market: market outlook
Fig. 14 Alzheimer’s disease diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alzheimer’s disease diagnostics market driver impact
Fig. 20 Alzheimer’s disease diagnostics market restraint impact
Fig. 21 Alzheimer’s disease diagnostics market strategic initiatives analysis
Fig. 22 Alzheimer’s disease diagnostics market: Diagnostics technique movement analysis
Fig. 23 Alzheimer’s disease diagnostics market: Diagnostics technique outlook and key takeaways
Fig. 24 Biomarkers market estimates and forecast, 2018 - 2030
Fig. 25 CSF biomarkers estimates and forecast, 2018 - 2030
Fig. 26 Blood based biomarkers market estimates and forecast, 2018 - 2030
Fig. 27 Imaging techniques estimates and forecast, 2018 - 2030
Fig. 28 Genetic testing market estimates and forecast, 2018 - 2030
Fig. 29 Cognitive assessment tests market estimates and forecasts,2018 - 2030
Fig. 30 Alzheimer’s disease diagnostics Market: Test type movement analysis
Fig. 31 Alzheimer’s disease diagnostics market: Test type outlook and key takeaways
Fig. 32 Triage market estimates and forecasts, 2018 - 2030
Fig. 33 Diagnosis market estimates and forecasts,2018 - 2030
Fig. 34 Screening market estimates and forecasts,2018 - 2030
Fig. 35 Alzheimer’s disease diagnostics market: End-use movement analysis
Fig. 36 Alzheimer’s disease diagnostics market: End-use outlook and key takeaways
Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 38 Diagnostic laboratories market estimates and forecasts,2018 - 2030
Fig. 39 Academic and research institutes market estimates and forecasts, 2018 - 2030
Fig. 40 Global Alzheimer’s disease diagnostics market: Regional movement analysis
Fig. 41 Global Alzheimer’s disease diagnostics market: Regional outlook and key takeaways
Fig. 42 Global Alzheimer’s disease diagnostics market share and leading players
Fig. 43 North America market share and leading players
Fig. 44 Europe market share and leading players
Fig. 45 Asia Pacific market share and leading players
Fig. 46 Latin America market share and leading players
Fig. 47 Middle East & Africa market share and leading players
Fig. 48 North America: SWOT
Fig. 49 Europe SWOT
Fig. 50 Asia Pacific SWOT
Fig. 51 Latin America SWOT
Fig. 52 MEA SWOT
Fig. 53 North America, by country
Fig. 54 North America
Fig. 55 North America market estimates and forecasts, 2018 - 2030
Fig. 56 U.S.
Fig. 57 U.S. market estimates and forecasts, 2018 - 2030
Fig. 58 Canada
Fig. 59 Canada market estimates and forecasts, 2018 - 2030
Fig. 60 Mexico
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Europe
Fig. 63 Europe market estimates and forecasts, 2018 - 2030
Fig. 64 UK
Fig. 65 UK market estimates and forecasts, 2018 - 2030
Fig. 66 Germany
Fig. 67 Germany market estimates and forecasts, 2018 - 2030
Fig. 68 France
Fig. 69 France market estimates and forecasts, 2018 - 2030
Fig. 70 Italy
Fig. 71 Italy market estimates and forecasts, 2018 - 2030
Fig. 72 Spain
Fig. 73 Spain market estimates and forecasts, 2018 - 2030
Fig. 74 Denmark
Fig. 75 Denmark market estimates and forecasts, 2018 - 2030
Fig. 76 Sweden
Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
Fig. 78 Norway
Fig. 79 Norway market estimates and forecasts, 2018 - 2030
Fig. 80 Asia Pacific
Fig. 81 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 82 China
Fig. 83 China market estimates and forecasts, 2018 - 2030
Fig. 84 Japan
Fig. 85 Japan market estimates and forecasts, 2018 - 2030
Fig. 86 India
Fig. 87 India market estimates and forecasts, 2018 - 2030
Fig. 88 Thailand
Fig. 89 Thailand market estimates and forecasts, 2018 - 2030
Fig. 90 South Korea
Fig. 91 South Korea market estimates and forecasts, 2018 - 2030
Fig. 92 Australia
Fig. 93 Australia market estimates and forecasts, 2018 - 2030
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecasts, 2018 - 2030
Fig. 96 Brazil
Fig. 97 Brazil market estimates and forecasts, 2018 - 2030
Fig. 98 Argentina
Fig. 99 Argentina market estimates and forecasts, 2018 - 2030
Fig. 100 Middle East and Africa
Fig. 101 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 102 South Africa
Fig. 103 South Africa market estimates and forecasts, 2018 - 2030
Fig. 104 Saudi Arabia
Fig. 105 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 106 UAE
Fig. 107 UAE market estimates and forecasts, 2018 - 2030
Fig. 108 Kuwait
Fig. 109 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 110 Market share of key market players- Alzheimer’s disease diagnostics market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alzheimer’s disease diagnostics market: market outlook
Fig. 14 Alzheimer’s disease diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alzheimer’s disease diagnostics market driver impact
Fig. 20 Alzheimer’s disease diagnostics market restraint impact
Fig. 21 Alzheimer’s disease diagnostics market strategic initiatives analysis
Fig. 22 Alzheimer’s disease diagnostics market: Diagnostics technique movement analysis
Fig. 23 Alzheimer’s disease diagnostics market: Diagnostics technique outlook and key takeaways
Fig. 24 Biomarkers market estimates and forecast, 2018 - 2030
Fig. 25 CSF biomarkers estimates and forecast, 2018 - 2030
Fig. 26 Blood based biomarkers market estimates and forecast, 2018 - 2030
Fig. 27 Imaging techniques estimates and forecast, 2018 - 2030
Fig. 28 Genetic testing market estimates and forecast, 2018 - 2030
Fig. 29 Cognitive assessment tests market estimates and forecasts,2018 - 2030
Fig. 30 Alzheimer’s disease diagnostics Market: Test type movement analysis
Fig. 31 Alzheimer’s disease diagnostics market: Test type outlook and key takeaways
Fig. 32 Triage market estimates and forecasts, 2018 - 2030
Fig. 33 Diagnosis market estimates and forecasts,2018 - 2030
Fig. 34 Screening market estimates and forecasts,2018 - 2030
Fig. 35 Alzheimer’s disease diagnostics market: End-use movement analysis
Fig. 36 Alzheimer’s disease diagnostics market: End-use outlook and key takeaways
Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 38 Diagnostic laboratories market estimates and forecasts,2018 - 2030
Fig. 39 Academic and research institutes market estimates and forecasts, 2018 - 2030
Fig. 40 Global Alzheimer’s disease diagnostics market: Regional movement analysis
Fig. 41 Global Alzheimer’s disease diagnostics market: Regional outlook and key takeaways
Fig. 42 Global Alzheimer’s disease diagnostics market share and leading players
Fig. 43 North America market share and leading players
Fig. 44 Europe market share and leading players
Fig. 45 Asia Pacific market share and leading players
Fig. 46 Latin America market share and leading players
Fig. 47 Middle East & Africa market share and leading players
Fig. 48 North America: SWOT
Fig. 49 Europe SWOT
Fig. 50 Asia Pacific SWOT
Fig. 51 Latin America SWOT
Fig. 52 MEA SWOT
Fig. 53 North America, by country
Fig. 54 North America
Fig. 55 North America market estimates and forecasts, 2018 - 2030
Fig. 56 U.S.
Fig. 57 U.S. market estimates and forecasts, 2018 - 2030
Fig. 58 Canada
Fig. 59 Canada market estimates and forecasts, 2018 - 2030
Fig. 60 Mexico
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Europe
Fig. 63 Europe market estimates and forecasts, 2018 - 2030
Fig. 64 UK
Fig. 65 UK market estimates and forecasts, 2018 - 2030
Fig. 66 Germany
Fig. 67 Germany market estimates and forecasts, 2018 - 2030
Fig. 68 France
Fig. 69 France market estimates and forecasts, 2018 - 2030
Fig. 70 Italy
Fig. 71 Italy market estimates and forecasts, 2018 - 2030
Fig. 72 Spain
Fig. 73 Spain market estimates and forecasts, 2018 - 2030
Fig. 74 Denmark
Fig. 75 Denmark market estimates and forecasts, 2018 - 2030
Fig. 76 Sweden
Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
Fig. 78 Norway
Fig. 79 Norway market estimates and forecasts, 2018 - 2030
Fig. 80 Asia Pacific
Fig. 81 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 82 China
Fig. 83 China market estimates and forecasts, 2018 - 2030
Fig. 84 Japan
Fig. 85 Japan market estimates and forecasts, 2018 - 2030
Fig. 86 India
Fig. 87 India market estimates and forecasts, 2018 - 2030
Fig. 88 Thailand
Fig. 89 Thailand market estimates and forecasts, 2018 - 2030
Fig. 90 South Korea
Fig. 91 South Korea market estimates and forecasts, 2018 - 2030
Fig. 92 Australia
Fig. 93 Australia market estimates and forecasts, 2018 - 2030
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecasts, 2018 - 2030
Fig. 96 Brazil
Fig. 97 Brazil market estimates and forecasts, 2018 - 2030
Fig. 98 Argentina
Fig. 99 Argentina market estimates and forecasts, 2018 - 2030
Fig. 100 Middle East and Africa
Fig. 101 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 102 South Africa
Fig. 103 South Africa market estimates and forecasts, 2018 - 2030
Fig. 104 Saudi Arabia
Fig. 105 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 106 UAE
Fig. 107 UAE market estimates and forecasts, 2018 - 2030
Fig. 108 Kuwait
Fig. 109 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 110 Market share of key market players- Alzheimer’s disease diagnostics market
